The Ly-6 group of alloantigens is one example of cell-surface antigen systems which are encoded by multigene families. At least five distinct Ly-6 antigens named Ly-6A, B, C, D and Th B have been identified by us and others. Decisive progress in the biochemical and serological characterization of these antigens strongly supports our working hypothesis of close structural relationships between the Ly-6 antigens. Direct support is rendered by analysis at the DNA level with the first Ly-6 cDNA probe available, which has confirmed the existence of multiple cross-hybridizing Ly-6DNA sequences in the mouse genome. The other breakthrough was the demonstration in several laboratories, including ours, that Ly-6.A antigens are important modulators allied with T cell activation, thus providing for the first time clues regarding the physiological role of Ly-6 for lymphocytes. In view of these new developments our project on the immunogenetics of Ly-6 will be redefined as follows: we will 1) Analyse the Ly-6A and related genes in detail, 2) Continue cellular immunological studies of Ly-6 using normal cells and cloned cell lines to test the hypothesis that Ly-6 is a signal modulator in cellular activation, 3) Continue the biochemical characterization of Ly-6 proteins to determine glycosylation and phosphorylation status and their form of plasma membrane association, 4) Look for Ly-6 involvement in multimolecular complexes on the cell surface, 5) Following the finding that Ly-6A is selectively induced by interferon, study modulation of Ly-6 antigen and gene expression by lymphokines on T cell, B cells and NK cells and correlate this with functional responses.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA038351-10
Application #
3176440
Study Section
Immunobiology Study Section (IMB)
Project Start
1984-04-01
Project End
1992-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
10
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
O'Connell, M J; Chua, R; Hoyos, B et al. (1996) Retro-retinoids in regulated cell growth and death. J Exp Med 184:549-55
Derguini, F; Nakanishi, K; Hammerling, U et al. (1995) 13,14-Dihydroxy-retinol, a new bioactive retinol metabolite. J Biol Chem 270:18875-80
Eppinger, T M; Buck, J; Hammerling, U (1993) Growth control or terminal differentiation: endogenous production and differential activities of vitamin A metabolites in HL-60 cells. J Exp Med 178:1995-2005
Garbe, A; Buck, J; Hammerling, U (1992) Retinoids are important cofactors in T cell activation. J Exp Med 176:109-17
Friedman, S; Palfree, R G; Sirlin, S et al. (1990) Analysis of three distinct Ly6-A-related cDNA sequences isolated from rat kidney. Immunogenetics 31:104-11
LeClair, K P; Bridgett, M M; Dumont, F J et al. (1989) Kinetic analysis of Ly-6 gene induction in a T lymphoma by interferons and interleukin 1, and demonstration of Ly-6 inducibility in diverse cell types. Eur J Immunol 19:1233-9
Palfree, R G; Sirlin, S; Dumont, F J et al. (1988) N-terminal and cDNA characterization of murine lymphocyte antigen Ly-6C.2. J Immunol 140:305-10
Toulon, M; Palfree, R G; Palfree, S et al. (1988) Ly-6 A/E antigen of murine T cells is associated with a distinct pathway of activation. Requirements for interferon and exogenous interleukin 2. Eur J Immunol 18:937-42
Hammelburger, J W; Palfree, R G; Sirlin, S et al. (1987) Demonstration of phosphatidylinositol anchors on Ly-6 molecules by specific phospholipase C digestion and gel electrophoresis in octylglucoside. Biochem Biophys Res Commun 148:1304-11
Palfree, R G; LeClair, K P; Bothwell, A et al. (1987) cDNA characterization of an Ly-6.2 gene expressed in BW5147 tumor cells. Immunogenetics 26:389-91

Showing the most recent 10 out of 12 publications